Potential applications of antithrombin concentrate in system inflammatory disorders. Introduction
Sacher, R.A.
Blood Coagulation and Fibrinolysis An International Journal in Haemostasis and Thrombosis 9 Suppl. 2: S1-S2
1998
ISSN/ISBN: 0957-5235 PMID: 9662463 Document Number: 496895
Document emailed within 1 workday
Related Documents
Dornheim, G.; Schön, R. 1982: Preparation and characterization of an antithrombin IIi concentrate Folia Haematologica 109(6): 870-877Roggendorf, M.; Delvos, U.; Nováková-Banet, A. 1991: Virus safety of pasteurized antithrombin IIi concentrate Thrombosis and Haemostasis 65(2): 212
Biescas, H.; Gensana, M.; Fernández, J.; Ristol, P.; Massot, M.; Watson, E.; Vericat, F. 1998: Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography Haematologica 83(4): 305-311
Patton, D.F.; Harper, J.L.; Wooldridge, T.N.; Gordon, B.G.; Coccia, P.; Haire, W.D. 1996: Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate Bone Marrow Transplantation 17(3): 443-447
Ladizinski, B.; Shannon, E.J.; Sanchez, M.R.; Levis, W.R. 2010: Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders Journal of Drugs in Dermatology: Jdd 9(7): 814-826
Furfaro, M.; Pesce, G.; Tessore, G. 1975: Alpha-1-fetoprotein in neoplastic diseases and in some inflammatory disorders of the digestive system Pathologica 67: 973-974
Beck, E.C.; Dustman, R.E.; Lewis, E.G. 1975: The use of the averaged evoked potential in the evaluation of central nervous system disorders International Journal of Neurology 9(3-4): 211-232
Dikke, G.B.; Ruzaeva, I.F. 1993: The use of the Shirsal concentrate in treating chronic inflammatory diseases of the uterine adnexa Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 30-33
Lyon-Caen, O.; Fontaine, B.; Gout, O.; Tourbah, A. 1994: Multiple sclerosis and other related inflammatory disorders of the central nervous system: differential diagnosis and treatment Acta Neurologica Belgica 94(2): 92-97
Fujiwara, Y. 2007: Introduction: "The scope of this forum" and "the necessity of introduction of compassionate use system in Japan" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 281-283
Dymarek, R.; Bidzińska, G.; Zwierzchowski, K.; Słupska, L.; Ptaszkowski, K.; Halski, T. 2015: Evaluation of the effectiveness of extracorporeal shock wave therapy in selected musculoskeletal system disorders of the inflammatory etiology--a critical review of the literature Wiadomosci Lekarskie 68(2): 183-192
Gotto, A.M. 1991: Hypercholesterolemia: new findings and clinical applications. Introduction American Journal of Medicine 91(1b): 1s-2s
Kanba, S. 2011: Introduction of treatment guideline for bipolar disorders made by the Japanese Society of Mood Disorders Seishin Shinkeigaku Zasshi 113(9): 863-866
Król-Grela, H.; Piastucka, B.; Skotnicki, A.B. 1988: The role of antithrombin III in disorders of blood coagulation Przeglad Lekarski 45(6): 516-520
Schuckit, M.A. 1992: An introduction and overview to clinical applications of neuroSPECT in psychiatry Journal of Clinical Psychiatry 53 Suppl: 3-6
Butch, S.H.; Distler, P.B. 2006: ISBT 128 blood labeling: introduction and reference laboratory applications Immunohematology 22(1): 30-36
Orzechowski, R.F. 1974: Study guide. Inflammatory disorders. II. Pharmacology of anti-inflammatory agents American Journal of Pharmacy and the Sciences Supporting Public Health 146(5): 150-161
Vadalà, G.; Di Martino, A.; Russo, F.; Tirindelli, M.C.; De Felice, L.; Agostini, F.; Papalia, R.; Denaro, V. 2016: Autologous bone marrow concentrate combined with platelet-rich plasma enhance bone allograft potential to induce spinal fusion Journal of Biological Regulators and Homeostatic Agents 30(4 Suppl 1: 165-172
Lew, S. 1998: HIV prevention among Asian and Pacific Islander American men who have sex with men: theories, research, applications, and policies. Introduction AIDS education and prevention: official publication of the International Society for AIDS Education 10(3 Suppl): 1-2
Jain, K.K. 2005: Applications and commercial potential of RNAi Idrugs: the Investigational Drugs Journal 8(12): 982-983